| (USD) | Sep 2022 | Y/Y change |
|---|---|---|
| Revenue | 2.89M | — |
| Operating expense | — | — |
| Net income | -6.89M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NASC returned -60.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -50.0% |
| 1 year | -60.0% |
| 5 years | -99.9% |
| 10 years | -100.0% |
| All-time high | $1,710.00 (Aug 2012) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NASC would be worth today ›No. Nascent Pharma Holdings, Inc. has not paid a dividend in the past 12 months.
Nascent Pharma Holdings, Inc. is part of the Healthcare sector.
Nascent Pharma Holdings, Inc. has a market cap of 884.12K USD, based on the latest quote.
